IT8967343A0 - Anticorpo umano monoclonale ed ibridoma che produce il medesimo - Google Patents

Anticorpo umano monoclonale ed ibridoma che produce il medesimo

Info

Publication number
IT8967343A0
IT8967343A0 IT8967343A IT6734389A IT8967343A0 IT 8967343 A0 IT8967343 A0 IT 8967343A0 IT 8967343 A IT8967343 A IT 8967343A IT 6734389 A IT6734389 A IT 6734389A IT 8967343 A0 IT8967343 A0 IT 8967343A0
Authority
IT
Italy
Prior art keywords
same
monoclonal antibody
human monoclonal
hybridoma producing
hybridoma
Prior art date
Application number
IT8967343A
Other languages
English (en)
Other versions
IT1232273B (it
Inventor
Shinichi Ohtsuka Hirosh Yokota
Hiroshi Noguchi Hiroshi Ochi
Masazumi Terashima
Masuhiro Kato
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of IT8967343A0 publication Critical patent/IT8967343A0/it
Application granted granted Critical
Publication of IT1232273B publication Critical patent/IT1232273B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IT8967343A 1988-05-10 1989-05-09 Anticorpo umano monoclonale ed ibridoma che produce il medesimo IT1232273B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11447388 1988-05-10

Publications (2)

Publication Number Publication Date
IT8967343A0 true IT8967343A0 (it) 1989-05-09
IT1232273B IT1232273B (it) 1992-01-28

Family

ID=14638614

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8967343A IT1232273B (it) 1988-05-10 1989-05-09 Anticorpo umano monoclonale ed ibridoma che produce il medesimo

Country Status (10)

Country Link
US (1) US5252480A (it)
EP (1) EP0341684B1 (it)
JP (1) JP2645665B2 (it)
AT (1) AT397803B (it)
BE (1) BE1001964A4 (it)
CH (1) CH681012A5 (it)
DE (1) DE68920624T2 (it)
FR (1) FR2631239B1 (it)
GB (1) GB2218703B (it)
IT (1) IT1232273B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
JPH04211393A (ja) * 1990-02-08 1992-08-03 Sumitomo Pharmaceut Co Ltd ヒトモノクローナル抗体及びそれを有効成分とする緑膿菌感染症治療剤
GB9105292D0 (en) * 1991-03-13 1991-04-24 Sandoz Ltd Improvements in or relating to organic compounds
US5648660A (en) * 1996-01-05 1997-07-15 Sterling Diagnostic Imaging, Inc. Method and apparatus for reducing noise in a radiation capture device
US6197582B1 (en) * 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
AU771224B2 (en) 1998-07-13 2004-03-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
DK1324776T4 (en) * 2000-10-12 2018-05-28 Genentech Inc CONCENTRATED PROTEIN FORMULATIONS WITH REDUCED VISCOSITY
WO2004055164A2 (en) * 2002-12-13 2004-07-01 Abgenix, Inc. System and method for stabilizing antibodies with histidine
US20050158303A1 (en) * 2003-04-04 2005-07-21 Genentech, Inc. Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
LT2335725T (lt) * 2003-04-04 2017-01-25 Genentech, Inc. Didelės koncentracijos antikūno ir baltymo kompozicijos
FR2859725B1 (fr) * 2003-09-16 2006-03-10 Neovacs Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine
KR20110128333A (ko) * 2009-03-06 2011-11-29 제넨테크, 인크. 항체 제제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
EP0215131B1 (en) * 1985-03-11 1992-06-17 Teijin Limited E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
JPS62215131A (ja) * 1986-03-13 1987-09-21 Kawasaki Heavy Ind Ltd 遠心クラツチ
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
WO1988008135A1 (en) * 1987-04-10 1988-10-20 Xoma Corporation Human monoclonal antibodies binding determinants of gram negative bacteria

Also Published As

Publication number Publication date
JP2645665B2 (ja) 1997-08-25
ATA111789A (de) 1993-11-15
AT397803B (de) 1994-07-25
GB2218703B (en) 1992-10-28
FR2631239A1 (fr) 1989-11-17
US5252480A (en) 1993-10-12
EP0341684B1 (en) 1995-01-18
FR2631239B1 (fr) 1994-05-27
GB8910395D0 (en) 1989-06-21
DE68920624T2 (de) 1995-07-27
JPH0284197A (ja) 1990-03-26
DE68920624D1 (de) 1995-03-02
GB2218703A (en) 1989-11-22
EP0341684A3 (en) 1990-01-17
CH681012A5 (it) 1992-12-31
EP0341684A2 (en) 1989-11-15
BE1001964A4 (fr) 1990-04-24
IT1232273B (it) 1992-01-28

Similar Documents

Publication Publication Date Title
IL88145A0 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
DK666389D0 (da) Monoklonalt antistof
FI962377A (fi) Humanisoituja vasta-aineita ja niiden käyttö
IL108199A0 (en) Monoclonal antibodies against the human il-4 receptor and hybridomas producing the same
IT8967343A0 (it) Anticorpo umano monoclonale ed ibridoma che produce il medesimo
DE3889062T2 (de) Monoklonaler Antikörper gegen humanen BCDF.
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
DE3587714T2 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
DE69024871T2 (de) Monoklonaler Antikörper gegen menschliches BCDF und Immuntestverfahren unter dessen Verwendung
DK474189A (da) Monoklonalt antistof
GB8901832D0 (en) Human monoclonal antibody and its production and use
DK413389D0 (da) Monoklonale antistoffer
DK370089A (da) Anti-urokinase monoklonale antistoffer
GB2207921B (en) Monoclonal antibody to omega-gliadin and hybridoma thereof
CS512290A3 (en) Mouse hybridoma ifna1-118 producing monoclonal antibody binding the human interferon alpha 1
CS511090A3 (en) Mouse hybridoma ifna2-n10 producing monoclonal antibody binding the human interferon alpha 2
ATE99332T1 (de) Monoklonale antikoerper gegen menschliche interleukin-4 und die sie erzeugenden hybridomen.
DK220688D0 (da) Monoklonalt antistof
EP0407430A4 (en) Therapeutic murine monoclonal antibody
EP0336441A3 (en) Anti-cpbii monoclonal antibody
EP0517918A4 (en) Monoclonal antibody against cardiac glycoside and utilization thereof
IE891095L (en) Human monoclonal antibodies
LV5784A4 (lv) Cilveka audzeju nekrozes faktora monoklonalas antivielas
IT1194260B (it) Linfochine e anticorpi monoclonali umani
FR2692786B1 (fr) Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530